In October 2023, the Journal of the American Medical Association examined adverse events associated with GLP-1 receptor agonists prescribed for weight loss, and researchers concluded that using the drugs increases the risk of gastrointestinal adverse effects, such as biliary disease, pancreatitis, bowel obstruction, and stomach paralysis
Youve probably heard of semaglutide, the powerful medication behind popular injectable treatments like Ozempic and Wegovy
Among field techniques, bioelectrical impedance analysis (BIA) and non-diagnostic ultrasound evaluation are widely used in clinical practice due to their non-invasive nature, ease of use, and low cost [72, 73]
Ozempic works for diabetes by mimicking GLP-1, a natural gut hormone